UK votes to stay in the EMA post-Brexit
The UK Parliament on Tuesday voted in favor of continuing the UK’s involvement with the European Medicines Agency (EMA) after the island leaves the EU.
The vote (305-301) means Parliament will make it a negotiating objective for the UK government to seek the UK’s participation in the European medicines regulatory network, according to the UK BioIndustry Association.
In a joint statement on behalf of the pharmaceutical industry in the UK, Mike Thompson, chief executive of the Association of the British Pharmaceutical Industry, and Steve Bates, chief executive of the BioIndustry Association, said:
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.